Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pyruvate (3 trials)
Asthma (Phase 2)
Cystic Fibrosis (Phase 1)
Fibrosis (Phase 1)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Trials (3 total)
Trial APIs (1 total)